Liraglutide studies: 1,219 papers with results
Page 14 of 25
- Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study.
Petit JM · The Journal of clinical endocrinology and metabolism · 2017
Non-randomized trial · 10 results
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.
Rizzo M · Cardiovascular diabetology · 2014
Non-randomized trial · 8 results
- Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus.
Suzuki D · Internal medicine (Tokyo, Japan) · 2013
Non-randomized trial · 9 results
- Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.
Rizvi AA · Expert opinion on biological therapy · 2015
Non-randomized trial · 6 results
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
Jensterle M · European journal of clinical pharmacology · 2015
Non-randomized trial · 8 results
- Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
Iepsen EW · Cell metabolism · 2018
Non-randomized trial · 7 results
- Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
Konstantinidou SK · Diabetes, obesity & metabolism · 2024
Non-randomized trial · 6 results
- Predictive factors of efficacy of combination therapy with basal insulin and liraglutide in type 2 diabetes when switched from longstanding basal-bolus insulin: Association between the responses of β- and α-cells to GLP-1 stimulation and the glycaemic control at 6 months after switching therapy.
Horie I · Diabetes research and clinical practice · 2018
Non-randomized trial · 5 results
- Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.
Jensterle M · Endocrine research · 2015
Non-randomized trial · 6 results
- Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment.
Zobel EH · Journal of diabetes and its complications · 2017
Non-randomized trial · 9 results
- Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.
Jacobsen LV · British journal of clinical pharmacology · 2009
Non-randomized trial · 6 results
- Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus.
Yan P · Diabetes research and clinical practice · 2011
Non-randomized trial · 1 result
- Assessment of complex treatment influence on systemic inflammation in overweight type 2 diabetes patients.
Said OV · Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2018
Non-randomized trial · 5 results
- The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls.
Kahal H · BMC endocrine disorders · 2015
Non-randomized trial · 16 results
- The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients.
Imamura S · The Tohoku journal of experimental medicine · 2013
Non-randomized trial · 5 results
- Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.
Rizzo M · The Journal of clinical endocrinology and metabolism · 2015
Non-randomized trial · 6 results
- Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study.
Mori Y · Diabetes technology & therapeutics · 2011
Non-randomized trial · 7 results
- Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes.
Nagai Y · Diabetes, obesity & metabolism · 2014
Non-randomized trial · 5 results
- Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Sherr JL · Diabetes care · 2016
Non-randomized trial · 8 results
- Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus.
Vergès B · Arteriosclerosis, thrombosis, and vascular biology · 2018
Non-randomized trial · 7 results
- Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
Osonoi T · PloS one · 2014
Non-randomized trial · 4 results
- Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.
Galderisi A · The Journal of clinical endocrinology and metabolism · 2018
Non-randomized trial · 5 results
- Liraglutide Treatment May Affect Renin and Aldosterone Release.
Sedman T · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2017
Non-randomized trial · 6 results
- Tolerance Does Not Develop Toward Liraglutide's Glucose-Lowering Effect.
Sedman T · The Journal of clinical endocrinology and metabolism · 2017
Non-randomized trial · 3 results
- Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase.
Malm-Erjefält M · Drug metabolism and disposition: the biological fate of chemicals · 2010
Non-randomized trial · 7 results
- Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W · The Journal of clinical endocrinology and metabolism · 2013
Non-randomized trial · 1 result
- Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
Yang M · Diabetes care · 2013
Non-randomized trial · 1 result
- Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results.
La Vignera S · Journal of clinical medicine · 2023
Non-randomized trial · 11 results
- Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia.
Adiels M · Diabetes, obesity & metabolism · 2019
Non-randomized trial · 5 results
- One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
Rosenstock J · Journal of diabetes and its complications · 2013
Non-randomized trial · 7 results
- Association of serum fetuin-B with insulin resistance and pre-diabetes in young Chinese women: evidence from a cross-sectional study and effect of liraglutide.
Xia X · PeerJ · 2021
Non-randomized trial · 1 result
- Comparative Effectiveness of Liraglutide versus Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Multicenter Propensity Score-Matched Real-World Study.
Khalil I · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
Observational study · 9 results
- Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.
Funch D · Diabetes, obesity & metabolism · 2019
Observational study · 3 results
- Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study.
Thomsen RW · Journal of the American Heart Association · 2021
Observational study · 4 results
- Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients.
Dai JW · Scientific reports · 2024
Observational study · 4 results
- Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study.
Gautier JF · Advances in therapy · 2015
Observational study · 8 results
- Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder.
Lähteenvuo M · JAMA psychiatry · 2025
Observational study · 12 results
- Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting.
Simioni N · Acta diabetologica · 2018
Observational study · 6 results
- Quality of Life, Glycemic Control, Safety and Tolerability Associated with Liraglutide or Insulin Initiation in Patients with Type 2 Diabetes in Germany: Results from the Prospective, Non-interventional LIBERTY Study.
Lundershausen R · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2020
Observational study · 9 results
- Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes.
Overbeek JA · Diabetes, obesity & metabolism · 2018
Observational study · 4 results
- The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes.
Giorgino F · Diabetes, obesity & metabolism · 2023
Observational study · 10 results
- Weight Outcomes With Empagliflozin as Compared With Liraglutide in Veterans With Type 2 Diabetes Mellitus.
Grabarczyk TR · The Annals of pharmacotherapy · 2020
Observational study · 4 results
- Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real-world setting: The XENSOR Study.
Gorgojo-Martínez JJ · International journal of clinical practice · 2019
Observational study · 8 results
- ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients.
Buysschaert M · Diabetes & metabolic syndrome · 2015
Observational study · 8 results
- Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure.
Zhou G · Medicine · 2026
Observational study · 11 results
- Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction.
Li Q · Journal of diabetes · 2024
Observational study · 4 results
- Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?
Moreno-Fernandez J · Primary care diabetes · 2020
Observational study · 8 results
- SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
Fu EL · BMJ (Clinical research ed.) · 2024
Observational study · 10 results
- Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
Deng Y · BMJ (Clinical research ed.) · 2022
Observational study · 9 results
- Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide.
Barkmeier AJ · Ophthalmology. Retina · 2026
Observational study · 18 results